Sickle Cell Disease Treatment Receives Rare Pediatric Disease Designation
Editas Medicine has developed a sickle cell disease (SCD) treatment, and it has recently received the Rare Pediatric Disease designation from the FDA. This means that their therapy, EDIT-301, is…